AMN Healthcare Earnings Call: Strike Tailwinds, Margin Pain

AMN Healthcare ((AMN)) has held its Q4 earnings call. Read on for the main highlights of the call.

AMN Healthcare’s latest earnings call struck a cautiously balanced tone, pairing evidence of operational stabilization with stark reminders of ongoing profitability challenges. Management emphasized strong cash generation, debt paydown, and Q4 outperformance versus guidance, yet acknowledged sharp year‑over‑year declines in revenue, EBITDA, and margins that will take time to repair.

Full-Year Revenue, Cash Flow and Debt Reduction

AMN reported 2025 revenue of $2.73 billion, reflecting an 8% decline from the prior year but still generating robust cash. Operating cash flow reached $269 million for the year, enabling the company to reduce total debt by $285 million and demonstrate balance sheet progress despite softer earnings.

Q4 Outperformance vs Guidance

Fourth-quarter revenue came in at $748 million, up 2% year over year and $18 million above the high end of guidance. Gross margin and adjusted EBITDA margin also landed at or slightly above the top of guidance ranges, signaling improved execution even as profitability remained under pressure versus last year.

Labor Disruption Revenue Surge

Labor disruption activity was a major swing factor, with Q4 revenue of $124 million nearly doubling the prior-year quarter. Management expects about $600 million of strike-related revenue in Q1, which should drive operating leverage but weighs on consolidated gross margin, with a roughly 130-basis-point drag in Q4 and an expected 300-basis-point hit in Q1.

Nurse & Allied Momentum

Nurse & Allied Solutions delivered Q4 revenue of $491 million, up 8% year over year and 36% sequentially, supported by a 6% sequential increase in travelers on assignment. Excluding labor disruption, management sees Nurse & Allied revenue rising 2%–4% year over year and 4%–6% sequentially in Q1, while the schools business posted a solid 10% annual increase.

Improving International and Search/Leadership Trends

International nurse staffing returned to sequential growth in Q4, a positive sign after prior softness in global demand. Management expects Allied International and Search to move back to year-over-year growth in Q1, with interim leadership and search already outperforming guidance in Q4 and search projected to be flat to slightly up.

Technology & AI Investments and VMS Enhancements

AMN continued to invest in its technology stack, rolling out ShiftWise Flex and enhancing VMS capabilities with advanced analytics, generative AI, and support for internal float pools. The company is deploying AI in recruiting, applicant tracking, and credentialing, while early pilots and client wins in Language Services hint at future margin upside from digital efficiencies.

Improving Working Capital Metrics

Working capital efficiency improved meaningfully, with days sales outstanding falling to 47 days in Q4, down 8 days year over year and 10 days sequentially. Q4 operating cash flow hit $76 million, and capital expenditures stayed modest at $8 million in the quarter and $36 million for the full year, preserving financial flexibility.

Operational Platform and Strike Playbook

Management highlighted a strengthened strike-response platform, including an event management system and dedicated operating model tailored to large labor disruptions. This infrastructure allowed AMN to handle two major indefinite events simultaneously while largely maintaining service levels in the core business and onboarding suppliers quickly.

Full-Year Revenue and Profit Declines

Despite operational wins, full-year profitability deteriorated, with revenue down 8% to roughly $2.7 billion and adjusted EBITDA falling 31% to $234 million. Adjusted EBITDA margin compressed 280 basis points to 8.6%, underscoring how far the company has to go in rebuilding earnings power from post-pandemic peaks.

Material Margin Compression in Q4

Margin pressure intensified in the fourth quarter, as consolidated gross margin dropped to 26.1%, down 370 basis points year over year and 300 basis points sequentially. Adjusted EBITDA of $54 million fell 27% from the prior year and margin slipped to 7.3%, a 290-basis-point decline that reflects mix shifts and added disruption costs.

Technology & Workforce Solutions Weakness

Technology & Workforce Solutions remained a weak spot, with Q4 revenue down 18% year over year to $88 million, or 14% lower excluding the divested Smart Square asset. Language Services revenue declined 9% and VMS revenue fell 28%, while segment gross margin contracted by about 920 basis points, highlighting both mix headwinds and the impact of portfolio changes.

Underlying Nurse & Allied Softness Excluding Strike

Beneath the strike surge, core demand in Nurse & Allied is still under pressure, though trends are improving. Excluding labor disruption, Q4 Nurse & Allied revenue was down 7% year over year versus a 13% drop in Q3, and Travel Nurse revenue declined 9%, pointing to lingering demand normalization after the pandemic boom.

Physician & Leadership Segment Pressure

The Physician & Leadership segment saw Q4 revenue slip to $170 million, down 2% year over year and 5% sequentially, with locum tenens flat annually but down 7% quarter over quarter. Management expects this segment to decline 5%–8% year over year in Q1, with interim staffing down mid-single digits, search flat to up, and locums mid-single digits lower.

Earnings and EPS Pressure

At the bottom line, AMN reported a Q4 net loss of $8 million, translating to a GAAP loss per share of $0.20, while adjusted EPS fell to $0.22 from $0.75 a year ago. For the full year, GAAP loss per share was -$2.48 and adjusted EPS dropped to $1.36 from $3.31, reflecting the combined impact of lower volumes, weaker mix, and higher operating costs.

Margin Drag and Incremental Costs from Labor Disruption

Labor disruption is a double-edged sword, adding large revenue but compressing margins and raising operating expenses. In Q4, strikes reduced consolidated gross margin by about 130 basis points and added roughly $5 million of incremental costs, while Q1 is expected to carry roughly $40 million of additional SG&A tied to labor events and a 300-basis-point gross-margin drag.

Leverage and Cash Position Still Elevated

AMN ended the year with $34 million in cash and equivalents against $775 million of total debt, resulting in net leverage of 3.3 times last twelve months EBITDA. Management expects leverage to fall below 3.0 times in Q1, but the still-elevated debt load keeps balance-sheet discipline and cash generation in sharp focus for investors.

Forward-Looking Guidance and Outlook

For Q1, management guided consolidated revenue to $1.225–$1.24 billion, driven by roughly $600 million of strike revenue, with adjusted EBITDA margin projected at 9.7%–10.2%. Excluding disruption, implied revenue of about $625–$640 million suggests modest underlying growth, and longer term the company is targeting 4%–6% organic revenue growth, slower operating expense growth, and 10%–15% annual adjusted EBITDA expansion.

AMN Healthcare’s earnings call painted a picture of a company leveraging its strike expertise and technology investments to stabilize operations while navigating cyclical and structural headwinds. With cash flow supporting debt reduction and select businesses returning to growth, the key question for investors is how quickly core demand and margins can recover as strike activity eventually normalizes.